JP2023544197A5 - - Google Patents

Info

Publication number
JP2023544197A5
JP2023544197A5 JP2023521060A JP2023521060A JP2023544197A5 JP 2023544197 A5 JP2023544197 A5 JP 2023544197A5 JP 2023521060 A JP2023521060 A JP 2023521060A JP 2023521060 A JP2023521060 A JP 2023521060A JP 2023544197 A5 JP2023544197 A5 JP 2023544197A5
Authority
JP
Japan
Prior art keywords
dried composition
mrna
freeze
aqueous solution
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023521060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544197A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/053776 external-priority patent/WO2022076562A1/en
Publication of JP2023544197A publication Critical patent/JP2023544197A/ja
Publication of JP2023544197A5 publication Critical patent/JP2023544197A5/ja
Pending legal-status Critical Current

Links

JP2023521060A 2020-10-06 2021-10-06 脂質ナノ粒子の改善された方法および製剤 Pending JP2023544197A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063088047P 2020-10-06 2020-10-06
US63/088,047 2020-10-06
PCT/US2021/053776 WO2022076562A1 (en) 2020-10-06 2021-10-06 Improved process and formulation of lipid nanoparticles

Publications (2)

Publication Number Publication Date
JP2023544197A JP2023544197A (ja) 2023-10-20
JP2023544197A5 true JP2023544197A5 (enExample) 2024-10-15

Family

ID=78500735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521060A Pending JP2023544197A (ja) 2020-10-06 2021-10-06 脂質ナノ粒子の改善された方法および製剤

Country Status (8)

Country Link
US (1) US20230372440A1 (enExample)
EP (1) EP4225268A1 (enExample)
JP (1) JP2023544197A (enExample)
KR (1) KR20230083323A (enExample)
CN (1) CN116546976A (enExample)
AU (1) AU2021358777A1 (enExample)
CA (1) CA3194863A1 (enExample)
WO (1) WO2022076562A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA42543A (fr) 2015-07-30 2018-06-06 Modernatx Inc Arn épitope peptidiques concatémériques
EP4011451A1 (en) 2015-10-22 2022-06-15 ModernaTX, Inc. Metapneumovirus mrna vaccines
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
WO2018170245A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Broad spectrum influenza virus vaccine
US11905525B2 (en) 2017-04-05 2024-02-20 Modernatx, Inc. Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
EP3746090A4 (en) 2018-01-29 2021-11-17 ModernaTX, Inc. RSV RNA Vaccines
US20230414516A1 (en) * 2020-11-16 2023-12-28 BioNTech SE Enhanced formulation stabilization and improved lyophilization processes
EP4274607A1 (en) 2021-01-11 2023-11-15 ModernaTX, Inc. Seasonal rna influenza virus vaccines
WO2022232585A1 (en) * 2021-04-29 2022-11-03 Modernatx, Inc. Lyophilization methods for preparing lipid formulated therapeutics
CN114557971B (zh) * 2022-04-25 2023-05-23 康希诺生物股份公司 一种核酸-脂质纳米颗粒的冷冻干燥保护剂及其制备方法和应用
WO2023212696A1 (en) * 2022-04-29 2023-11-02 Modernatx, Inc. Lyophilized human cytomegalovirus vaccines
CN115624630A (zh) * 2022-12-19 2023-01-20 北京荷牧生物科技有限公司 冻干保护组合物及其应用和基于该组合物的核酸脂质纳米颗粒冻存方法
WO2024160936A1 (en) 2023-02-03 2024-08-08 Glaxosmithkline Biologicals Sa Rna formulation
AU2024260120A1 (en) 2023-04-27 2025-11-06 Glaxosmithkline Biologicals Sa Influenza virus vaccines
WO2024223724A1 (en) 2023-04-27 2024-10-31 Glaxosmithkline Biologicals Sa Influenza virus vaccines
WO2025029323A1 (en) * 2023-07-28 2025-02-06 Vitrivax, Inc. Compositions, methods, and uses for polynucleotide formulations for drying and prolonged storage

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
CA2569664C (en) 2004-06-07 2013-07-16 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
JP4874097B2 (ja) * 2004-06-18 2012-02-08 テルモ株式会社 水難溶性カンプトテシン含有リポソーム製剤
PL2578685T3 (pl) 2005-08-23 2020-01-31 The Trustees Of The University Of Pennsylvania Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
CA2740000C (en) 2008-10-09 2017-12-12 Tekmira Pharmaceuticals Corporation Improved amino lipids and methods for the delivery of nucleic acids
EP3269395A1 (en) 2008-11-07 2018-01-17 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
KR101766408B1 (ko) 2009-06-10 2017-08-10 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
CA2769670C (en) 2009-07-31 2018-10-02 Ethris Gmbh Rna with a combination of unmodified and modified nucleotides for protein expression
DE102011076149A1 (de) * 2011-05-19 2012-11-22 Rovi Cosmetics International Gmbh Ladungsgeber für ein vesikuläres Trägersystem eines UV-Schutzmittels für die Haut oder die Haare
ES2795110T3 (es) * 2011-06-08 2020-11-20 Translate Bio Inc Lípidos escindibles
PE20181541A1 (es) 2011-10-27 2018-09-26 Massachusetts Inst Technology Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
BR112014024131A2 (pt) 2012-03-29 2017-07-25 Shire Human Genetic Therapies lipídios catiônicos ionizáveis
FR2991327B1 (fr) * 2012-06-05 2018-04-13 Hemarina Procede de lyophilisation d'hemoglobine d'annelides
JP6586075B2 (ja) 2013-03-14 2019-10-02 トランスレイト バイオ， インコーポレイテッド メッセンジャーｒｎａの精製方法
BR112015022505A2 (pt) 2013-03-14 2017-10-24 Shire Human Genetic Therapies avaliação quantitativa para eficiência do cap de rna mensageiro
EP3083556B1 (en) 2013-12-19 2019-12-25 Novartis AG Lipids and lipid compositions for the delivery of active agents
US9850269B2 (en) 2014-04-25 2017-12-26 Translate Bio, Inc. Methods for purification of messenger RNA
JP6557722B2 (ja) 2014-05-30 2019-08-07 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 核酸の送達のための生分解性脂質
HUE060907T2 (hu) 2014-06-25 2023-04-28 Acuitas Therapeutics Inc Új lipidek és lipid nanorészecske formulációk nukleinsavak bevitelére
US9840479B2 (en) 2014-07-02 2017-12-12 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
EP3247363A4 (en) 2015-01-21 2018-10-03 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
EP3247398A4 (en) 2015-01-23 2018-09-26 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
WO2016205691A1 (en) 2015-06-19 2016-12-22 Massachusetts Institute Of Technology Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
PT3313829T (pt) 2015-06-29 2024-07-08 Acuitas Therapeutics Inc Formulações de lípidos e de nanopartículas lipídicas para a administração de ácidos nucleicos
CN106466299B (zh) * 2015-08-19 2021-09-28 上海本素医药科技有限公司 以人参皂苷为膜材的空白脂质体、其制备方法及应用
JP6948313B6 (ja) 2015-09-17 2022-01-14 モデルナティエックス インコーポレイテッド 治療剤の細胞内送達のための化合物および組成物
HRP20230209T1 (hr) 2015-10-28 2023-04-14 Acuitas Therapeutics Inc. Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
US20180361342A1 (en) * 2015-12-08 2018-12-20 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Method for Preparing Liposome
WO2017117528A1 (en) 2015-12-30 2017-07-06 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
LT3436077T (lt) 2016-03-30 2025-06-25 Intellia Therapeutics, Inc. Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams
EP3468610A1 (en) * 2016-06-09 2019-04-17 OPKO Biologics Ltd. Long-acting oxyntomodulin formulation and methods of producing and administering same
CA3043033A1 (en) 2016-11-10 2018-05-17 Translate Bio, Inc. Improved ice-based lipid nanoparticle formulation for delivery of mrna
EP3585892B8 (en) 2017-02-27 2022-07-13 Translate Bio, Inc. Methods for purification of messenger rna
CA3054321A1 (en) 2017-02-27 2018-08-30 Translate Bio, Inc. Methods for purification of messenger rna
EP3585886B1 (en) 2017-02-27 2023-11-22 Translate Bio, Inc. Large scale synthesis of messenger rna
MX2019013752A (es) * 2017-05-16 2020-07-20 Translate Bio Inc Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones.
KR20210091120A (ko) * 2018-08-29 2021-07-21 트랜슬레이트 바이오 인코포레이티드 Mrna-로딩된 지질 나노입자를 제조하는 개선된 공정

Similar Documents

Publication Publication Date Title
JP2023544197A5 (enExample)
JP2016535065A5 (enExample)
JP2005537798A5 (enExample)
JP5618402B2 (ja) 咀嚼性ソフトカプセル剤の製造方法
CN110102082B (zh) 一种贝类酶解液中重金属镉的去除方法
CN111297911A (zh) 缓释抗逆性益生菌晶球及其制备方法
JP2020531415A5 (enExample)
CN114885984B (zh) 不黏牙的真空冷冻干燥水果酸奶脆块的制备方法
CN110810783A (zh) 一种油菜蜂花粉破壁方法
CN102058548B (zh) 一种供注射用的盐酸氨溴索组合物及其制备方法
JP5432180B2 (ja) 半導体基板のｈｆ処理におけるウォーターマークの低減
CN105457104B (zh) 一种骨组织工程多孔陶瓷支架的制备方法
CN102429314A (zh) 一种大尺寸食品整体低频微波脱水方法
JP4918054B2 (ja) 軟質化方法および軟質化種子
JP2022513081A5 (enExample)
JP6033630B2 (ja) 渋柿の加工食品及びその製造方法
CN108576791A (zh) 一种银耳干制品的制备方法
JP2020162440A (ja) 乾燥野菜の製造方法、および乾燥野菜
JP2011155909A (ja) 加工ナタデココの形成方法、加工ナタデココの復元方法、及び加工ナタデココ
CN109090227A (zh) 一种带壳荔枝干的制作方法
CN110037157A (zh) 一种提高植物乳杆菌在口香糖制备及贮藏过程中稳定性的方法
KR101730379B1 (ko) 감가공 식품의 제조방법 및 이를 이용한 감가공 식품
CN109527462A (zh) 一种荔枝和龙眼干制食品的制备方法
CN106279721A (zh) 基于Maillard反应的植物蛋白纳米凝胶及其制备
JP2016036267A (ja) 軟質化キノコの製造方法